RxSight, Inc. (RXST) income statement
RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$5.01+0.18 (+3.73%)
Close on Nov 18, 2026Market cap $208.38MP/E –Yield –
RxSight, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 77.5%
- Operating margin
- -43.2%
- Net margin
- -36.8%
- Return on equity, FY2025
- -14.0%
Financial strength
- Current ratio
- 4.07
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 16.6%
Valuation
- P/E ratio
- –
- Price to sales
- 1.63
- Price to book
- 0.79
- Dividend yield
- –
See a number that looks wrong?